Price $74.60 |
Market Cap
19.25B
|
Sector Health Care |
Div. Growth
1.00%
|
|
P/E
-
|
P/B
-
|
P/S
0.1
|
Dividend %
2.60%
|
|
P/CF
40.5
|
P/FCF
9.0
|
Op. Cash Flow
3.19M
|
FCF
8.3
|
|
Op. Margin
-
|
Net Margin
-0.70%
|
ROE
94.30%
|
ROI
-16.70%
|
|
ROA
-2.90%
|
EPS Growth
-340.80%
|
Current Ratio
1.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Societal CDMO Inc (SCTL) | $1.19 | - | - | 106.1M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.26 | - | - | 129.6M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $1.58 | - | - | 20.1M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.43 | - | - | 16.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.92 | - | - | 110.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
